Default mode network coherence in treatment-resistant major depressive disorder during electroconvulsive therapy

J Affect Disord. 2016 Nov 15:205:130-137. doi: 10.1016/j.jad.2016.06.059. Epub 2016 Jun 27.

Abstract

Background: Functional connectivity in the "default mode network" (DMN) is changed in depression, and evidence suggests depression also affects the DMN's spatial topography and might cause a dissociation between its anterior and posterior regions. As antidepressive treatment affects anterior and posterior regions of the network differently, how depression and treatment change DMN-organization is crucial for understanding their mechanisms. We present a novel way of assessing the coherence of a network's regions to the network as a whole, and apply this to investigate treatment-resistant depression and the effects of electroconvulsive therapy (ECT).

Methods: Resting-state functional MRI was collected from 16 patients with treatment-resistant depression before and after ECT and 16 healthy controls matched for age and sex. For each subject, the mean time series of the DMN was used as a regressor for each voxel within the DMN, creating a map of "network coherence" (NC). The obtained maps were compared across groups using permutation testing.

Results: NC was significantly decreased in depressed subjects in the precuneus and the angular gyrus. With ECT the NC normalized in responders (n=8), but not in non-responders (n=8).

Conclusions: We present a novel method of investigating within-network coherence and apply this to show that in depression, a large area of the DMN shows a decrease in coherence to the network as a whole. Although tentative due to the small sample size, we find that this effect is not present after ECT in those improving clinically, but persists in patients not responding to ECT.

Keywords: Connectivity; Default mode network; Depression; Electroconvulsive therapy; Resting-state; Treatment.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use
  • Brain / physiopathology*
  • Case-Control Studies
  • Depressive Disorder, Major* / physiopathology
  • Depressive Disorder, Major* / therapy
  • Depressive Disorder, Treatment-Resistant* / physiopathology
  • Depressive Disorder, Treatment-Resistant* / therapy
  • Electroconvulsive Therapy*
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Nerve Net / physiopathology*

Substances

  • Antidepressive Agents